Lori Kunkel

Lori Kunkel

Director/Board Member bei ORIC PHARMACEUTICALS, INC.

Vermögen: 2 Mio $ am 31.03.2024

66 Jahre
Health Technology
Consumer Services
Retail Trade

Profil

Lori Anne Kunkel is currently an Independent Director at Nurix Therapeutics, Inc., Oric Pharmaceuticals, Inc., K36 Therapeutics, Inc., and Enliven Therapeutics, Inc. She is also the Owner of Lak505, LLC.
Previously, Dr. Kunkel held positions such as Associate Director-Clinical Development at Chiron Corp., Independent Director at Curis, Inc., Director at Tocagen, Inc., Director at Loxo Oncology, Inc., Director at Amphivena Therapeutics, Inc., Director at Harpoon Therapeutics, Inc., Director at Maverick Therapeutics, Inc., Head-Clinical Scientist at Genentech, Inc., Chief Medical Officer at Pharmacyclics LLC, Vice President-Medical Affairs at Genitope Corp., Vice President-Clinical Development at Xencor, Inc., Chief Medical Officer at Syndax Pharmaceuticals, Inc., Chief Medical Officer at Proteolix, Inc., and Chief Medical Officer at ACT Biotech, Inc. She also held positions at Onyx Pharmaceuticals, Inc., XOMA Corp., ZymoGenetics, Inc., Salmedix, Inc., and DNAX Research, Inc. Additionally, she was a Member of the Bone Marrow Transplant Unit at the University of California.
Dr. Kunkel obtained a doctorate degree from the University of Southern California and an undergraduate degree from the University of California San Diego.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
08.04.2024 45 926 ( 0,11% ) 807 838 $ 31.03.2024
21.03.2024 54 027 ( 0,11% ) 794 197 $ 31.03.2024
14.06.2023 0 ( -.--% ) - $ 31.03.2024

Aktive Positionen von Lori Kunkel

UnternehmenPositionBeginn
NURIX THERAPEUTICS, INC. Director/Board Member 01.07.2019
ORIC PHARMACEUTICALS, INC. Director/Board Member 09.06.2020
ENLIVEN THERAPEUTICS, INC. Director/Board Member 09.04.2024
Director/Board Member -
Lak505, LLC Corporate Officer/Principal 01.04.2012
Alle aktiven Positionen von Lori Kunkel

Ehemalige bekannte Positionen von Lori Kunkel

UnternehmenPositionEnde
CURIS, INC. Director/Board Member 30.09.2022
Director/Board Member 01.08.2021
FORTE BIOSCIENCES, INC. Chief Tech/Sci/R&D Officer 15.04.2019
LOXO ONCOLOGY INC Chief Tech/Sci/R&D Officer 01.08.2013
░░░░░░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Lori Kunkel im Detail an

Ausbildung von Lori Kunkel

University of Southern California Doctorate Degree
University of California San Diego Undergraduate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Lori Kunkel im Detail an

Beziehungen

96

Beziehungen ersten Grades

27

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen8
XOMA CORPORATION

Health Technology

CURIS, INC.

Health Technology

XENCOR, INC.

Health Technology

SYNDAX PHARMACEUTICALS, INC.

Health Technology

NURIX THERAPEUTICS, INC.

Health Technology

ORIC PHARMACEUTICALS, INC.

Health Technology

HARPOON THERAPEUTICS, INC.

Health Technology

ENLIVEN THERAPEUTICS, INC.

Health Technology

Private Unternehmen16

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

DNAX Research, Inc.

Health Technology

Health Technology

Retail Trade

Health Technology

Lak505, LLC

Health Technology

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Lori Kunkel